FDA Inspection 1293576 — Ashley L. Devonshire, M.D., MPH

Ashley L. Devonshire, M.D., MPH — FEI 3039281824

The FDA completed an inspection of Ashley L. Devonshire, M.D., MPH on November 20, 2025 in Cincinnati, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 20, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cincinnati, OH (United States)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance